Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.16924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Chihiro Yoshida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
- Department of General Thoracic Surgery, Kochi Health Sciences Center, Kochi, Japan.
- Department of Molecular Oncologic Pathology, Faculty of Medicine, Kagawa University, Kagawa, Japan; ychihiro.sky@gmail.com.
- Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Zitieren
APA
Yoshida, C., Kadota, K., Ibuki, E., Ishikawa, R., Haba, R., & Yajima, T. (2024). Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.16924
Vancouver
Yoshida C, Kadota K, Ibuki E, Ishikawa R, Haba R, Yajima T. Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.16924
BibTeX
@article{Yoshida2024,
author = {Yoshida, Chihiro and Kadota, Kyuichi and Ibuki, Emi and Ishikawa, Ryou and Haba, Reiji and Yajima, Toshiki},
title = {Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16924}
}
EUVIMED